skin cancer: malignant melanoma

Studies

ID Name Stage Status
LX01-315 Allovectin-7/LX01-315 metastatic
 active
111482 Immunotherapeutic als adjuvant therapy in patients with resected melanoma adjuvant
 active
101.321-13/07 ChemoSens MM metastatic
 active
MM-ADJ-5 Interferon Hochdosis adjuvant adjuvant
 closed
D1532C00006 Dacarbazin ± AZD6244 for melanoma with BRAF mutations metastatic
 closed
CY-503 metastatic 2nd line
 closed